Overview

Update
Status
Acquired by on April 14, 2014
Total Equity Funding
$18M in 3 Rounds
Headquarters:
Cambridge, Massachusetts
Description:
GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.
Founders:
Categories:
Medical Device, Health Care, Biotechnology
Website:
http://gnubio.com

Company Details

Update

GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.

Funding Rounds (4) - $22.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2012$10M / Series B0
Sep, 2012$4.5M / Grant0
Sep, 2011$5M / Series A0
Dec, 2010$3M / Series A0

Current Team (5)

Update

Offices/Locations (1)

Update
  • Office

    1 Kendall Square

    Building 1400, Suite 14201

    Cambridge, Massachusetts 02139

    United States

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos